February 13th, 2024
CARB-X funds the Myers Research Group to develop enhanced oral antibiotics to treat a range of serious drug-resistant bacterial infections
Researchers at the Andrew G Myers Research Group at the Harvard University Department of Chemistry and Chemical Biology are engineering synthetic antibiotics that directly target bacteria which cause lower respiratory tract and skin and soft tissue infections.